1. Home
  2. BY vs STOK Comparison

BY vs STOK Comparison

Compare BY & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Byline Bancorp Inc.

BY

Byline Bancorp Inc.

HOLD

Current Price

$38.18

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$28.15

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BY
STOK
Founded
1914
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
BY
STOK
Price
$38.18
$28.15
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$36.00
$39.20
AVG Volume (30 Days)
243.5K
679.1K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
1.48%
N/A
EPS Growth
5.09
92.73
EPS
1.73
N/A
Revenue
N/A
$184,420,000.00
Revenue This Year
$16.89
N/A
Revenue Next Year
$3.15
$77.49
P/E Ratio
$22.35
N/A
Revenue Growth
N/A
404.50
52 Week Low
$25.57
$20.32
52 Week High
$40.05
$40.22

Technical Indicators

Market Signals
Indicator
BY
STOK
Relative Strength Index (RSI) 49.72 41.29
Support Level $38.31 $28.02
Resistance Level $39.48 $33.61
Average True Range (ATR) 0.81 1.23
MACD -0.04 -0.30
Stochastic Oscillator 37.21 14.14

Price Performance

Historical Comparison
BY
STOK

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through a wholly-owned subsidiary of Byline Bank.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: